Private Market View

Genesis Therapeutics

Drug Discovery · Burlingame, CA · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$327.4M
Last round
Early Stage VC (Series B)
Aug 2023
How much has Genesis Therapeutics raised?
$327.4Macross 3 recorded rounds · Nov 2020Aug 2023

Most recently, Genesis Therapeutics raised $224.0M in its Early Stage VC (Series B) (Aug 2023).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·The complete investor list — 22 names
  • ·Watchlist + deal alerts for Genesis Therapeutics
Create free account
No card required

Round by round

3 rounds
Aug 2023Early Stage VC (Series B)$224.0M
+ 1 more investors · free account
Jun 2022Early Stage VC$23.9MSEC filing
33 investors participated
Nov 2020Early Stage VC$49.5MSEC filing
24 investors participated
For fundraisers
Raising for a company like Genesis Therapeutics?

22 investors have backed Genesis Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 22 investors →

Frequently asked

How much has Genesis Therapeutics raised?
Genesis Therapeutics has raised $327.4M in total across 3 recorded funding rounds.
When was Genesis Therapeutics's last funding round?
Genesis Therapeutics's most recent recorded round was Early Stage VC (Series B) in Aug 2023, raising $224.0M.